XBI State Street SPDR S&P Biotech ETF
Company Analysis
Latest News
🟢 XBI is trading 3.07% up today as biotech IPOs raised $161.7 million
XBI is trading 3.07% up at $153.87, aligned with a broader biotech-sector rally. - Lilly-backed TRex Bio and Retension Pharmaceuticals raised about $161.7...
Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
The biotech sector is experiencing a significant rally, with the XBI ETF up 2.50%, driven by strong investor sentiment following a pair of successful Initial...
Biotech Sector Declines Without Clear Catalyst
The biotech sector, as measured by the XBI ETF, is down more than 2% in the current session, continuing a recent trend of weakness. There is no single,...
🔴 XBI is trading 3.17% down today amid broad biotech-sector pressure
XBI is trading 3.17% down now at $151.24, with broad-based negative sentiment across biotechnology weighing on the sector. - The sector update cites increased...
Biotech Sector Declines on Broad-Based Negative Sentiment
The biotechnology sector, as measured by the XBI ETF, traded down 2.50% in the current session amid a generally negative sentiment for the industry. No single,...
Biotech Sector Declines on Negative Company-Specific News
The biotech sector, as measured by the XBI ETF, traded lower in the pre-market session following disappointing news from several companies. Eli Lilly announced...
🔴 XBI is trading 3.27% down today as broad risk-off trading pressures biotech valuations
XBI is trading 3.27% down at $156.58, with broad risk-off trading weighing on biotech valuations. - The Nasdaq is down 1.00%, while rising crude oil and the...
Biotech Sector Surges in Pre-Market on Multiple Positive News Snippets
The biotechnology sector, as measured by the XBI ETF, is trading significantly higher in the pre-market session. This move appears to be driven by a collection...
Biotech Sector Rallies on Major AI Collaboration Deal and Positive Clinical News
The biotechnology sector is trading higher, driven by a significant collaboration between Boehringer Ingelheim and AI-powered drug discovery company...
🟢 XBI is trading 3.38% up today on stronger biotech R&D demand
XBI is trading 3.38% up now at $159.39 after improving pharmaceutical and biotech R&D demand, a healthier funding environment, and renewed M&A optimism. -...
Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
The biotechnology sector, as measured by the XBI ETF, is trading significantly higher today, driven by a positive outlook from industry bellwether Thermo...
🔴 XBI is trading 3.05% down today following pelacarsen Phase 3 failure
XBI is trading 3.05% down now at $152.79 as biotechnology shares weaken broadly amid pressure from the pelacarsen Phase 3 failure. - Pelacarsen missed its...
Biotech Sector Gains on Patent News and Continued Positive Momentum
The biotech sector, as measured by the XBI ETF, is trading significantly higher today, led by a more than 35% surge in Purple Biotech (PPBT) shares after the...
Biotech Sector Declines Amid Broad Market Sell-Off
The biotechnology sector, as measured by the XBI ETF, experienced a significant downturn of -4.24% during the regular trading session. This decline coincided...
🔴 XBI is trading 3.07% down today amid concern over a hawkish interest-rate stance
XBI is trading 3.07% down now at $163.06 as investors sell biotech and other high-risk growth assets amid concern that Federal Reserve Chair Kevin Warsh’s...
🟢 XBI is trading 3% up today as biotech shares extend recent momentum
XBI is trading 3.02% up now at $169.13 as biotech shares extend recent momentum amid positive sector sentiment. - The broader market is also modestly higher...
Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
The biotech sector, represented by the XBI ETF, is trading higher today, influenced by a general market upswing ahead of key inflation data and major tech...
Biotech Sector Continues Upward Trend on Strong Momentum
The biotechnology sector, as measured by the XBI ETF, is extending its recent gains, building on strong positive momentum from earlier in the week. This rally...
🔴 XBI is trading 3.4% down today after investors took profits following Moderna’s surge
XBI is trading 3.4% down at $163.72 as investors appear to take profits following Moderna’s dramatic cancer-vaccine-driven surge. - Edesa Biotech’s $25...
Biotech Sector Cools Off After Moderna-Sparked Rally
The biotech sector is experiencing a pullback after a significant surge the previous day, which was ignited by positive cancer vaccine trial results from...